original ) (raw )Prospective Evaluation of 11C-Choline Positron Emission Tomography/Computed Tomography and Diffusion-Weighted Magnetic Resonance Imaging for the Nodal Staging of Prostate Cancer with a High Risk of Lymph Node Metastases
Karin Haustermans
European Urology, 2011
View PDFchevron_right
11C-choline positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: …
Francesco Castellucci
European …, 2008
View PDFchevron_right
11C-Choline Positron Emission Tomography/Computerized Tomography for Preoperative LymphNode Staging in Intermediate-Risk and High-Risk Prostate Cancer: Comparison with Clinical Staging Nomograms
Francesco Castellucci
European Urology, 2008
View PDFchevron_right
Utility of Choline Positron Emission Tomography/Computed Tomography for Lymph Node Involvement Identification in Intermediate- to High-risk Prostate Cancer: A Systematic Literature Review and Meta-analysis
Andrea Guttilla , Pier Muzzio
European Urology, 2013
View PDFchevron_right
11C-acetate PET/CT in pre-therapeutic lymph node staging in high-risk prostate cancer patients and its influence on disease management - a retrospective study
Torbjörn Sundström
EJNMMI Research, 2014
View PDFchevron_right
Adequate Diagnostic Performance of Combined [<sup>18</sup>F]-Fluormethylcholine PET-CT with Diffusion-Weighted MRI in Primary Staging of High Risk Prostate Cancer
Martijn Boomsma
Advances in Molecular Imaging, 2016
View PDFchevron_right
Value of PET/CT and MR Lymphography in Treatment of Prostate Cancer Patients with Lymph Node Metastases
Satoru Takahashi
2012
View PDFchevron_right
Comparison of 68Ga-PSMA-I/T PET-CT and Multiparametric MRI for Locoregional Staging of Prostate Cancer Patients: A Pilot Study
aziz gültekin
Urologia Internationalis
View PDFchevron_right
Prospective comparison of 18F-PSMA-1007 PET/CT, whole-body MRI and CT in primary nodal staging of unfavourable intermediate- and high-risk prostate cancer
Hannu Aronen
European Journal of Nuclear Medicine and Molecular Imaging, 2021
View PDFchevron_right
18F-Fluorocholine PET Whole-Body MRI in the Staging of High-Risk Prostate Cancer
Gráinne Murphy
American Journal of Roentgenology, 2018
View PDFchevron_right
Accuracy of 68 Ga-PSMA PET-CT and PET-MRI in lymph node staging for localized prostate cancer
Journal einstein (São Paulo)
einstein (São Paulo), 2022
View PDFchevron_right
Comparison of [11C]choline Positron Emission Tomography With T2- and Diffusion-Weighted Magnetic Resonance Imaging for Delineating Malignant Intraprostatic Lesions
Damien Bolton
International Journal of Radiation Oncology*Biology*Physics, 2015
View PDFchevron_right
Comparison of integrated whole-body [11C]choline PET/MR with PET/CT in patients with prostate cancer
Tobias Maurer
2013
View PDFchevron_right
Evaluation of Prostate Cancer with 11C- and 18F-Choline PET/CT: Diagnosis and Initial Staging
Oliver Hakenberg
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2016
View PDFchevron_right
One-Stop-Shop Whole-Body 68Ga-PSMA-11 PET/MRI Compared with Clinical Nomograms for Preoperative T and N Staging of High-Risk Prostate Cancer
Andrei Gafita
Journal of Nuclear Medicine, 2018
View PDFchevron_right
A comparison between 68Ga-labeled prostate-specific membrane antigen-PET/CT and multiparametric MRI for excluding regional metastases prior to radical prostatectomy
Jack Baniel
Abdominal Radiology, 2020
View PDFchevron_right
Utility of [11C]choline PET/CT in guiding lesion-targeted salvage therapies in patients with prostate cancer recurrence localized to a single lymph node at imaging: Results from a pathologically validated series
maria picchio
Urologic Oncology: Seminars and Original Investigations, 2014
View PDFchevron_right
[18F]-fluorocholine positron-emission/computed tomography for lymph node staging of patients with prostate cancer: preliminary results of a prospective study
Anthony Hutton
BJU International, 2010
View PDFchevron_right
MRI and 11C acetate PET/CT for prediction of regional lymph node metastasis in newly diagnosed prostate cancer
Håkan Ahlström
Radiology and Oncology, 2018
View PDFchevron_right
Histologically Confirmed Diagnostic Efficacy of 18F-rhPSMA-7 PET for N-Staging of Patients with Primary High-Risk Prostate Cancer
Michael Herz
Journal of Nuclear Medicine, 2019
View PDFchevron_right
Simultaneous whole-body PET/MRI with integrated multiparametric MRI for primary staging of high- risk prostate cancer
Stephan Kruck
101. Deutscher Röntgenkongress und 9. Gemeinsamer Kongress der DRG und ÖRG, 2020
View PDFchevron_right
Multiparametric whole-body 3.0-T MRI in newly diagnosed intermediate- and high-risk prostate cancer: diagnostic accuracy and interobserver agreement for nodal and metastatic staging
Ahmed.hashim Ahmed
European Radiology, 2018
View PDFchevron_right
Does focal incidental 18F-FDG PET/CT uptake in the prostate have significance?
Karen Kurdziel
Abdominal Imaging, 2015
View PDFchevron_right